Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/25
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 11/28/22
End: 11/17/25
Due: 11/17/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases | NCT06626919 | Arcellx, Inc. | user2@example.com | None | 2025-01-31 | 2028-04-30 | 2029-04-30 | - | - | 2025-07-14 |
| Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS | NCT05457010 | Arcellx, Inc. | user2@example.com | None | 2022-11-28 | 2025-11-17 | 2026-11-17 | - | - | 2025-07-14 |